Summary
In a double-blind randomized clinical trial co-trimazine or co-trimoxazole was given to 212 patients with urinary tract infections. Co-trimazine (1.0 g) was given once daily and co-trimoxazole was administered as control treatment in a standard dosage of 0.96 g twice daily. The cure rate for co-trimazine was 90% and for co-trimoxazole 87%. Bacterial resistance was only observed in a few cases. Side-effects were observed in 11.8% of the patients treated with co-trimazine and in 15.5% of those treated with co-trimoxazole. The side effects were generally mild and only once in each group was treatment interrupted.
Zusammenfassung
Cotrimazin oder Co-trimoxazol wurden in einem randomisierten Doppelblindversuch 212 Patienten mit Harnwegsinfektionen verabreicht. Co-trimazin (1 g) wurde einmal täglich und Co-trimoxazol als Kontrollbehandlung wurde in der gebräuchlichen Standarddosierung von 0,96 g zweimal täglich gegeben. Der Heilungserfolg betrug in der Co-trimazin-Gruppe 90% und bei Co-trimoxazol 87%. Es wurden nur wenige Fälle bakterieller Resistenz beobachtet. Unter Co-trimazin-Therapie wurden bei 11,8% und mit Co-trimoxazol bei 15,5% der Fälle Nebenwirkungen registriert. Die Nebenwirkungen waren im allgemeinen leicht und veranlaßten nur einmal in jeder Behandlungsgruppe den Abbruch der Therapie.
Similar content being viewed by others
Literature
Skjerven, O., Bergan, T. Double-blind comparison of sulphonamide-trimethoprim combinations in acute uncomplicated urinary tract infections. Infection 7 Suppl. 4 (1979) S398-S400.
Lövestad, A., Gästrin, B., Lundström, R. A clinical study of cotrimazine in comparison with co-trimoxazole and sulphalene in urinary tract infections. Infection 7 Suppl. 4 (1979) S401-S403.
Allgulander, S., Holm, S., Lundgren, S. The use of co-trimazine and co-trimoxazole in elderly patients with urinary tract infections. Infection 7 Suppl. 4 (1979) S404-S407.
Belsheim, J., Gnarpe, H., Helleberg, A., Svensson, A. Clinical study of co-trimazine in urinary tract infections: a comparison with nitrofurantoin. Infection 7 Suppl. 4 (1979) S411-S413.
Örtengren, B., Magni, L., Bergan, T. Development of sulphonamide-trimethoprim combinations for urinary tract infections. Infection 7 Suppl. 4 (1979) S371-S381.
Acar, J., Ekström, B., Fellner, H., Forsgren, U., Guibert, J., Huitfeldt, B., Kitzis, M. D., Magni, L., Örtengren, B. Synergistic activity of co-trimazine and co-trimoxazole in the urine. Infection 7 Suppl. 4 (1979) S324-S329.
Manual of Clinical Microbiology.Lennette, E. H., Spaulding, E. H., Truant, J. P. (Eds.) American Society for Microbiology, Washington, D. C., 1974.
Hofstetter, A.: Efficacy of Triglobe® in hospitalized patients with complicated and uncomplicated urinary tract infections. J. Int. Med. Res. 8 (1980) in press.
Knothe, H. The effect of a combined preparation of trimethoprim and sulphamethoxazole following short-term and long-term administration on the flora of the human gut. Chemotherapy 18 (1973) 285–296.
Reeves, D. S., Faiers, M. C., Pursell, R. E., Brumfitt, W. Trimethoprim-sulphamethoxazole: comparative study in urinary infection in hospital. Br. Med. Journal 1 (1969) 541.
Sietzen, W., Knothe, H.: Effect of trimethoprim, trimethoprimsulphamethoxazole and sulphamethoxazole on the occurrence of drug resistant enterobacteriaceae in the human bowel flora. Proc. 10th Int. Congr. Chemotherapy (1978) 660–662.
Stamey, T. A., Condy, M., Mihara, G. Prophylactic efficacy of nitrofurantoin macrocrystals and trimethoprim-sulfamethoxazole in urinary infections. N Engl. J. Med. 296 (1977) 780–783.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sietzen, W., Rugendorff, E.W. Co-trimazine once daily in urinary tract infections in comparison with co-trimoxazole given twice daily — A double-blind randomized study. Infection 9, 91–95 (1981). https://doi.org/10.1007/BF01640635
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF01640635